Memorial Sloan Kettering Cancer Center Jobs

Memorial Sloan Kettering Cancer Center

Applications Close:

1275 York Ave, New York, NY 10065, USA

5 Star Employer Ranking

"Chief Attending, Radiochemistry & Imaging Sciences Service"

Academic Connect
Applications Close

Chief Attending, Radiochemistry & Imaging Sciences Service

Exciting Opportunity at MSK: Chief Attending, Radiochemistry & Imaging Sciences Service

  • Spearhead the development of innovative radiochemistry research initiatives aimed at the clinical translation of scientific discoveries into patient care.
  • Collaborate closely with the Chief of the Molecular Imaging and Therapy Service (MITS) and the Radiochemistry and Molecular Imaging Probe (RMIP) Core to align radiochemistry efforts with clinical operations and translational research priorities.
  • Lead a multidisciplinary team advancing translational radiochemistry and radiopharmaceutical science, overseeing their own laboratory and coordinating research activities across the Service.
  • Provide scientific and strategic vision for the design, synthesis, evaluation and clinical translation of novel radiotracers and radiopharmaceuticals for diagnostic and therapeutic applications.
  • Foster a collaborative, interdisciplinary environment by mentoring faculty, trainees and technical staff and promoting excellence in radiochemistry research and development.

Key Requirements

  • Nationally and internationally recognized scientific leader with a proven record of innovation in the development, validation, and clinical translation of diagnostic and theranostic probes for molecular imaging and therapy.
  • Experience with core facility operations including cyclotron production, radiolabeling, regulatory compliance and the ability to strategically integrate these capabilities into research and clinical translation.
  • Demonstrated success in building collaborative teams and partnerships across clinical, research, and translational domains.
  • Excellent organizational, leadership, and communication skills, with the ability to articulate vision, set priorities, and advance institutional research and clinical goals.

Core Skills

  • PhD in Radiochemistry (or closely related discipline) with deep expertise in radiochemistry, molecular probe design, and radiopharmaceutical development for imaging and therapy.
  • Strong record of peer-reviewed publications and research funding.
  • Experience with technology transfer, intellectual property, or industry collaborations preferred.
  • Commitment to mentorship, education, and faculty development.

Application Instructions

Submit C.V., letter of interest, and references in your application submission to:

Contact Name: Valentina Salkow
Contact Email: salkowv@mskcc.org

Pay Range: $300,000 - $440,000

Additional Details about the positions

Today, the Service combines state-of-the-art cyclotron production and radiolabeling with research in tumor-targeting probes, multi-modality imaging (PET, MRI, optical) and targeted radionuclide therapies to deliver precision cancer diagnosis and therapy. The Service houses eleven independent research labs- each with their own individual research portfolios. Each year, the Service's work results in novel first-in human trials.

10

Whoops! This job is not yet sponsored…

I own this job - Please upgrade it to a full listing

Or, view more options below

View full job details

See the complete job description, requirements, and application process

Stay on their radar

Join the talent pool for Memorial Sloan Kettering Cancer Center

Join Talent Pool

Express interest in this position

Let Memorial Sloan Kettering Cancer Center know you're interested in Chief Attending, Radiochemistry & Imaging Sciences Service

Add this Job Post to FavoritesExpress Interest

Get similar job alerts

Receive notifications when similar positions become available

Share this opportunity

Send this job to colleagues or friends who might be interested

5,410 Jobs Found

AcademicJobs.com

New York, New York
Staff / Administration
Add this Job Post to Favorites
Closes: Mar 11, 2026
View More